Featuring perspectives from Dr Yelena Y Janjigian and Dr Zev Wainberg, including the following topics:

• Introduction: First-Line Therapy for Metastatic Gastroesophageal (GE) Cancers — the Bottom Line (0:00)
• Updates on Immunotherapy in GE Cancers (18:51)
• Targeting HER2 (33:11)
• Targeting Claudin 18.2 — Zolbetuximab (54:42)

CME information and select publications